Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
07/29/2003 | US6599724 Pharmaceutical composition for use in the treatment of blood disorders |
07/29/2003 | US6599720 Methods for making poly-β-1→4-N-acetylglucosamine |
07/29/2003 | US6599719 For therapy of rheumatoid arthritis, tumors |
07/29/2003 | US6599718 Growth hormone secretagogue related receptors and nucleic acids |
07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
07/29/2003 | US6599699 Methods for diagnosing a disorder by assaying for MAGE-3 |
07/29/2003 | US6599698 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
07/29/2003 | US6599695 Method for assaying for early gene expression in neuroblasts |
07/29/2003 | US6599690 Chemical cleaning of biological material |
07/29/2003 | US6599516 Malleable implant containing solid element that resorbs or fractures to provide access channels |
07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
07/29/2003 | CA2146965C Cyclin complex rearrangement and uses related thereto |
07/29/2003 | CA2122044C Hiv immunotherapeutics |
07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
07/29/2003 | CA2067136C Growth hormone antagonists |
07/29/2003 | CA2053586C Defined culture medium for cho cells |
07/25/2003 | CA2425623A1 Promoter promoting expression of a foreign gene in root and shoot apex |
07/24/2003 | WO2003060150A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
07/24/2003 | WO2003060149A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
07/24/2003 | WO2003060147A2 Method of obtaining purified enterochromaffin cells and methods of using same |
07/24/2003 | WO2003060143A2 Efficient protein expression system |
07/24/2003 | WO2003060138A1 In increasing gene transfer efficiency by pre-incubation with endothelial cells |
07/24/2003 | WO2003060133A2 Selective plant growth using d-amino acids |
07/24/2003 | WO2003060130A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
07/24/2003 | WO2003060108A1 A suprabasal breast cell line with stem cell properties |
07/24/2003 | WO2003060107A1 Separation, preparation and use of human embryo dorsal root ganglion (drg) stem cell |
07/24/2003 | WO2003060106A1 Method and device for identifying substances capable of modulating adipocyte differentiation |
07/24/2003 | WO2003060096A2 Assay for the detection of factors that modulate the expression of ingap |
07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
07/24/2003 | WO2003060087A2 Rapid method of selecting cells for gene disruption by homologous recombination |
07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
07/24/2003 | WO2003060084A2 Methods for making polynucleotides and purifying double-stranded polynucleotides |
07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
07/24/2003 | WO2003060077A2 Endothelial stem cells, populations, methods of isolation and use thereof |
07/24/2003 | WO2003060072A2 Recombinant polypeptides |
07/24/2003 | WO2003060071A2 Albumin fusion proteins |
07/24/2003 | WO2003060068A2 Oxa1p enhanced protein secretion |
07/24/2003 | WO2003060065A2 Adapter-directed display system |
07/24/2003 | WO2003060062A2 Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells |
07/24/2003 | WO2003060061A1 Chamber with adjustable volume for cell culture and organ assist |
07/24/2003 | WO2003059953A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
07/24/2003 | WO2003059951A2 Novel anti-igf-ir antibodies and uses thereof |
07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
07/24/2003 | WO2003059944A2 Gb virus b based replicons and replicon enhanced cells |
07/24/2003 | WO2003059940A1 Biomolecule transduction motif sim-2-btm and the use thereof |
07/24/2003 | WO2003059938A1 Chromatin remodeling protein as a marker expressed by stromal progenitor cells |
07/24/2003 | WO2003059932A2 Methods of inducing or enhancing connective tissue repair |
07/24/2003 | WO2003059927A1 Compositions and methods relating to endometrial specific genes and proteins |
07/24/2003 | WO2003059923A2 Methods and compositions for generating a genetically modified animal using lentiviral vectors |
07/24/2003 | WO2003059365A1 Remedy for dysmnesia |
07/24/2003 | WO2003059285A2 Rip2: a method of signaling in the innate and adaptive immune systems |
07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
07/24/2003 | WO2003059272A2 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
07/24/2003 | WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells |
07/24/2003 | WO2003059260A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
07/24/2003 | WO2003059259A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
07/24/2003 | WO2003059252A2 Use of a novel cell surface protease from group b streptococcus |
07/24/2003 | WO2003059072A1 Cultured and encapsulated pancreatic stem cells |
07/24/2003 | WO2003059061A1 Biomaterial derived from vertebrate liver tissue |
07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
07/24/2003 | WO2003028651A3 Antipsychotic agents stimulate neurogenesis in brain |
07/24/2003 | WO2003022032A3 Method for increasing stress tolerance in plants |
07/24/2003 | WO2003020927A3 Creation of artificial internal ribosome entry site (ires) elements |
07/24/2003 | WO2003018612A3 Extracellular messengers |
07/24/2003 | WO2003012061A3 Methods and compositions relating to plasmacytoid dendritic cells |
07/24/2003 | WO2003006661A3 Transgenic plants expressing cobalamin binding proteins |
07/24/2003 | WO2003006651A3 Vascular tissue preferred promoters |
07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
07/24/2003 | WO2003000714A3 Compositions and methods for preventing protein aggregation in neurodegenerative diseases |
07/24/2003 | WO2002102839A3 Novel g-protein coupled receptors and dna sequences thereof |
07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
07/24/2003 | WO2002090531A3 Peptidylarginine deiminase 6 |
07/24/2003 | WO2002088307A3 Humanized antibodies |
07/24/2003 | WO2002086107A3 A method for differentiating stem cells into insulin-producing cells |
07/24/2003 | WO2002077011A3 Oxidation-reduction sensitive green fluorescent protein variants |
07/24/2003 | WO2002074807A3 Chimpanzee erythropoietin (chepo) - immunoadhesins |
07/24/2003 | WO2002062961A3 Peptide scaffold encapsulation of tissue cells and uses thereof |
07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
07/24/2003 | WO2002059338A3 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
07/24/2003 | WO2002059300A3 Double-stranded rna-mediated gene suppression |
07/24/2003 | WO2002052018A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
07/24/2003 | US20030140378 Antirrhinum majus/arabidopsis nucleotide sequences coding and expressing centroradialis (CEN)/terminal flower-1 (TF1) genes in apical meristems; controlling fruit propagation; papermaking |
07/24/2003 | US20030140377 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
07/24/2003 | US20030140376 Optimized t-dna transfer and vectors therefor |
07/24/2003 | US20030140370 Fungal glyoxal oxidases |
07/24/2003 | US20030140366 Regulation of quinolate phosphoribosyl transferase expression |
07/24/2003 | US20030140361 CCR6 chemokine receptor disruptions, compositions and methods relating thereto |
07/24/2003 | US20030140360 Transgenic mammals and reagents for improving long-term memory |
07/24/2003 | US20030139591 Isolation and use of tissue growth-inducing Frzb protein |
07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
07/24/2003 | US20030139581 Protocadherin materials and methods |
07/24/2003 | US20030139579 LO-CD2b antibody and uses thereof for inhibiting T cell activation and proliferation |
07/24/2003 | US20030139573 Lipid binding protein 3 |
07/24/2003 | US20030139572 Novel compounds |
07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
07/24/2003 | US20030139351 NKT cell-activating agents containing alpha-glycosylceramides |